Explore how cancer cells develop resistance to Antibody-Drug Conjugates (ADCs) and the scientific strategies to overcome these challenges.
Explore how mTOR inhibitors are revolutionizing breast cancer treatment by targeting cellular pathways in resistant cancers, with insights into drug mechanisms and future therapies.
Breakthrough in triple-negative breast cancer treatment using LHRH peptide-decorated cross-linked micelles for targeted drug delivery